This morning we watched agilon health inc. drop -13.4% to a price of $23.21 per share. The large-cap Medical Distribution company is now trading -20.49% below its average target price of $29.19. Analysts have set target prices ranging from $22.0 to $41.0 per share for agilon health inc., and have given the stock an average rating of buy.
agilon health inc. has an elevated short interest of 22.9%. The stock's short ratio, or the number of days needed for all shorts to cover their positions, is 15.63. Only 1.11% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders. 106.1% of agilon health inc. shares are held by institutional investors, which indicates a high level of confidence in the stock.
Institutions Invested in agilon health inc.
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2022-12-31 | Clayton, Dubilier & Rice, LLC | 47% | 194,611,308 | $4,516,928,280 |
| 2022-12-31 | FMR, LLC | 11% | 46,671,306 | $1,083,240,969 |
| 2022-12-31 | Morgan Stanley | 9% | 38,439,976 | $892,191,807 |
| 2022-12-31 | Capital World Investors | 9% | 37,918,473 | $880,087,723 |
| 2022-12-31 | Wellington Management Group, LLP | 6% | 22,745,297 | $527,918,322 |
| 2022-12-31 | Vanguard Group, Inc. (The) | 5% | 19,247,393 | $446,731,973 |
| 2022-12-31 | Capital Research Global Investors | 3% | 13,428,559 | $311,676,842 |
| 2022-12-31 | Durable Capital Partners LP | 2% | 8,842,728 | $205,239,708 |
| 2022-12-31 | Blackrock Inc. | 2% | 8,686,090 | $201,604,140 |
| 2022-12-31 | Rock Springs Capital Management, LP | 2% | 7,872,500 | $182,720,717 |
